Anavex Life Sciences Corp (NASDAQ:AVXL)
| 8.72 Delayed Data As of May 18 |  -0.71 / -7.53%Today’s Change | 7.13 Today|||52-Week Range 31.50 | -49.71% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Favus Elliot Jay Director |  Sale | 5/21/2021 | 145,000 | $11.70 | $1.7M | -25.34% |
Favus Elliot Jay Director |  Buy | 5/21/2021 | 50,000 | $2.96 | $148.0K | -25.34% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 50,000 | $0.92 | $46.0K | -25.34% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 37,500 | $1.20 | $45.0K | -25.34% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 1,500 | $6.11 | $9.2K | -25.34% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 1,500 | $5.66 | $8.5K | -25.34% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 1,500 | $5.64 | $8.5K | -25.34% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 1,500 | $5.57 | $8.4K | -25.34% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 1,500 | $4.90 | $7.4K | -25.34% |